564 related articles for article (PubMed ID: 24298059)
1. Repurposing CRISPR/Cas9 for in situ functional assays.
Malina A; Mills JR; Cencic R; Yan Y; Fraser J; Schippers LM; Paquet M; Dostie J; Pelletier J
Genes Dev; 2013 Dec; 27(23):2602-14. PubMed ID: 24298059
[TBL] [Abstract][Full Text] [Related]
2. A single blastocyst assay optimized for detecting CRISPR/Cas9 system-induced indel mutations in mice.
Sakurai T; Watanabe S; Kamiyoshi A; Sato M; Shindo T
BMC Biotechnol; 2014 Jul; 14():69. PubMed ID: 25042988
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
[TBL] [Abstract][Full Text] [Related]
4. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
5. Efficient CRISPR/Cas9 genome editing in a salmonid fish cell line using a lentivirus delivery system.
Gratacap RL; Regan T; Dehler CE; Martin SAM; Boudinot P; Collet B; Houston RD
BMC Biotechnol; 2020 Jun; 20(1):35. PubMed ID: 32576161
[TBL] [Abstract][Full Text] [Related]
6. Improved genome editing in human cell lines using the CRISPR method.
Munoz IM; Szyniarowski P; Toth R; Rouse J; Lachaud C
PLoS One; 2014; 9(10):e109752. PubMed ID: 25303670
[TBL] [Abstract][Full Text] [Related]
7. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells.
Zhou Y; Zhu S; Cai C; Yuan P; Li C; Huang Y; Wei W
Nature; 2014 May; 509(7501):487-91. PubMed ID: 24717434
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
[TBL] [Abstract][Full Text] [Related]
10. Adapting CRISPR/Cas9 for functional genomics screens.
Malina A; Katigbak A; Cencic R; Maïga RI; Robert F; Miura H; Pelletier J
Methods Enzymol; 2014; 546():193-213. PubMed ID: 25398342
[TBL] [Abstract][Full Text] [Related]
11. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
13. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library.
Koike-Yusa H; Li Y; Tan EP; Velasco-Herrera Mdel C; Yusa K
Nat Biotechnol; 2014 Mar; 32(3):267-73. PubMed ID: 24535568
[TBL] [Abstract][Full Text] [Related]
15. Genetic screens and functional genomics using CRISPR/Cas9 technology.
Hartenian E; Doench JG
FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
[TBL] [Abstract][Full Text] [Related]
16. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
Chakraborty C; Teoh SL; Das S
Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
[TBL] [Abstract][Full Text] [Related]
17. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
18. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
19. CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells.
Bellec J; Bacchetta M; Losa D; Anegon I; Chanson M; Nguyen TH
Curr Gene Ther; 2015; 15(5):447-59. PubMed ID: 26264708
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
Jo YI; Suresh B; Kim H; Ramakrishna S
Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
